论文部分内容阅读
格林-巴利综合征(GBS)系免疫介导的周围神经病,它是以周围神经和神经根的脱髓鞘及小血管周围淋巴细胞及巨噬细胞的炎性反应为病理特点的自身免疫性疾病。目前静脉滴注大剂量免疫球蛋白治疗GBS效果肯定[1,2],但不同时间应用大剂量免疫球蛋白治疗效果是否相同尚待临床观察。我们
Guillain-Barre syndrome (GBS) is an immune-mediated peripheral neuropathy that is characterized by autoimmune pathologies characterized by the demyelination of peripheral nerves and nerve roots and the inflammatory responses of lymphocytes and macrophages surrounding small vessels disease. The current intravenous infusion of high-dose immunoglobulin treatment of GBS affirmed [1,2], but at different times the application of high-dose immunoglobulin therapeutic effect remains to be clinical observation. we